Novartis Sues To Protect Market For Epilepsy Drug
Novartis AG has filed a patent infringement suit in federal court in New Jersey to stave off generic competition for its popular antiepileptic drug Trileptal, which hauled in $352 million in...To view the full article, register now.
Already a subscriber? Click here to view full article